Cargando…
The sodium-glucose co-transporter 2 inhibitor velagliflozin reduces hyperinsulinemia and prevents laminitis in insulin-dysregulated ponies
There are no registered veterinary drugs for treating insulin dysregulation and preventing insulin-associated laminitis in horses. Velagliflozin is a sodium-glucose co-transport 2 inhibitor that reduces renal glucose reabsorption, promotes glucosuria, and consequently, decreases blood glucose and in...
Autores principales: | Meier, Alexandra, Reiche, Dania, de Laat, Melody, Pollitt, Christopher, Walsh, Donald, Sillence, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136744/ https://www.ncbi.nlm.nih.gov/pubmed/30212530 http://dx.doi.org/10.1371/journal.pone.0203655 |
Ejemplares similares
-
The efficacy and safety of velagliflozin over 16 weeks as a treatment for insulin dysregulation in ponies
por: Meier, A., et al.
Publicado: (2019) -
Insulin and incretin responses to grazing in insulin‐dysregulated and healthy ponies
por: Fitzgerald, Danielle M., et al.
Publicado: (2018) -
The effect of different grazing conditions on the insulin and incretin response to the oral glucose test in ponies
por: Fitzgerald, Danielle M., et al.
Publicado: (2019) -
The cresty neck score is an independent predictor of insulin dysregulation in ponies
por: Fitzgerald, Danielle M., et al.
Publicado: (2019) -
Demographic, morphologic, hormonal and metabolic factors associated with the rate of improvement from equine hyperinsulinaemia-associated laminitis
por: Sillence, Martin, et al.
Publicado: (2022)